Explore

Trendline Trendline
Biopharma Sector Sees Q2 Earnings Surge Amid FDA Policy Controversy and IPO Boom

Biopharma Sector Sees Q2 Earnings Surge Amid FDA Policy Controversy and IPO Boom

Biopharma Sector Sees Q2 Earnings Surge Amid FDA Policy Controversy and IPO Boom
Trendline Trendline
Sarepta Therapeutics to Release Q2 2026 Financial Results, Highlighting Genetic Medicine Leadership

Sarepta Therapeutics to Release Q2 2026 Financial Results, Highlighting Genetic Medicine Leadership

Sarepta Therapeutics to Release Q2 2026 Financial Results, Highlighting Genetic Medicine Leadership
Trendline Trendline
Otis Worldwide Exceeds Q2 2026 Revenue Expectations, Adjusts Full-Year EPS Guidance

Otis Worldwide Exceeds Q2 2026 Revenue Expectations, Adjusts Full-Year EPS Guidance

Otis Worldwide Exceeds Q2 2026 Revenue Expectations, Adjusts Full-Year EPS Guidance
Trendline Trendline
Schrödinger to Announce Second Quarter 2026 Financial Results, Impacting Investors

Schrödinger to Announce Second Quarter 2026 Financial Results, Impacting Investors

Schrödinger to Announce Second Quarter 2026 Financial Results, Impacting Investors
Trendline Trendline
Community Health Systems Reports Q2 Earnings Shortfall Amid Market Challenges

Community Health Systems Reports Q2 Earnings Shortfall Amid Market Challenges

Community Health Systems Reports Q2 Earnings Shortfall Amid Market Challenges
Trendline Trendline
Sonoco Reports Strong Second Quarter 2026 Results with Increased Net Income

Sonoco Reports Strong Second Quarter 2026 Results with Increased Net Income

Sonoco Reports Strong Second Quarter 2026 Results with Increased Net Income
Reuters Reuters
Moody's quarterly profit jumps on bond issuance activity strength

Moody's quarterly profit jumps on bond issuance activity strength

July 22 (Reuters) - Moody's reported a jump in second-quarter profit on Wednesday, as strong bond issuance activity drove growth in its ratings business.
Trendline Trendline
Stevanato Group to Announce Q2 2026 Financial Results in August

Stevanato Group to Announce Q2 2026 Financial Results in August

Stevanato Group to Announce Q2 2026 Financial Results in August
Trendline Trendline
Roche Appoints Dan Malarek as New CEO of Diagnostics North America

Roche Appoints Dan Malarek as New CEO of Diagnostics North America

Roche Appoints Dan Malarek as New CEO of Diagnostics North America
Trendline Trendline
Swatch Group Reports Lower-Than-Expected Net Profit Despite Sales Growth in First Half

Swatch Group Reports Lower-Than-Expected Net Profit Despite Sales Growth in First Half

Swatch Group Reports Lower-Than-Expected Net Profit Despite Sales Growth in First Half
Trendline Trendline
Nuvation Bio's Brain Cancer Drug Shows Promise, Boosting Stock

Nuvation Bio's Brain Cancer Drug Shows Promise, Boosting Stock

Nuvation Bio's Brain Cancer Drug Shows Promise, Boosting Stock
Trendline Trendline
Ceribell to Announce Q2 2026 Financial Results Amidst Neurological Tech Advancements

Ceribell to Announce Q2 2026 Financial Results Amidst Neurological Tech Advancements

Ceribell to Announce Q2 2026 Financial Results Amidst Neurological Tech Advancements